PIPages
Labs

Sally McFall

Northwestern University, IL·Biomedical Engineering

Many infectious diseases can be treated, but only if they are diagnosed first. In places without laboratories, diagnosis is often the weakest link.

Fields

Biomedical Engineering

Medicine & Clinical Research

Public Health & Epidemiology

Topics

point-of-care diagnostics

POC testing

hepatitis C

Grants
2 known grants, through Jul 2029

What they work on

  1. Develop a DASH platform test that detects hepatitis C viral RNA from a fingerstick blood sample in 15 minutes, so active infection can be diagnosed in a single step without a laboratory.
  2. Evaluate the diagnostic accuracy of the DASH HCV test on stored plasma and prospectively collected whole blood at three clinical sites in Nigeria, where infection rates and viral diversity are high.
  3. Build a pipeline of point-of-care diagnostic technologies for people living with HIV in low-resource settings by identifying needs, recruiting and mentoring projects, and moving devices to clinical evaluation.
  4. Support home-grown diagnostic device development with African biomedical engineering partners in Nigeria, Tanzania, Mali, Senegal and South Africa, focusing on low-cost tests that work without reliable electricity or refrigeration.

More about the research

Hepatitis C virus (HCV) is an example. It infects over 58 million people, and HCV-related cirrhosis or liver cancer kills about 300,000 people each year. The common theme of this work is building fast, simple, low-cost diagnostic tests that work at the point of care (POC), in clinics with little infrastructure, in Africa and in underserved U.S. communities.

Why it matters

A cheap, portable test that confirms active hepatitis C in one visit could let patients start curative treatment right away. This may reduce liver cancer in Nigeria and other low- and middle-income countries. It could also help people who inject drugs, people experiencing homelessness, incarcerated people and rural U.S. communities. Rugged, low-cost devices could likewise improve care for people living with HIV where labs are scarce.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Active HCV diagnosis to support prevention of HCC in LMICs

NIH · Aug 2024 – Jul 2029

Technology Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)

NIH · Sep 2018 – Jul 2028

Closest labs

Samuel K Sia

Columbia University, NY·Biomedical Engineering

Integrate plasma filtration from whole blood and PRECISE magnetic bead nucleic-acid extraction with plasmonic PCR to create a sample-to-answer hepatitis C RNA test.

Saurabh Mehta

Cornell University, NY·Public Health & Epidemiology

Enable testing of point-of-care diagnostic devices on human samples and patients by providing access to biobanks and diverse patient groups at partner sites in New York, Uganda, Ecuador and India.

Waseem Asghar

Florida Atlantic University, FL·Biomedical Engineering

Develop a disposable microchip that selectively detects HIV-1 directly from whole blood samples, rather than detecting antibodies against the virus.

The school

Northwestern University: 71 labs on PI Pages, $1.3B a year on research, 536 research doctorates a year.

More about Northwestern University

Reach out

A start for your email. Fill in the brackets.